[
  {
    "sentence": "2,213 (25.1%) patients had at least one somatic mutation, and 38% (843 out of 2,213) patients with CH harbored more than one mutation (Figure 1A).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The median VAF for CH mutations was 0.044 in blood compared to 0.005 in the corresponding tumor, presumably due to the infiltration of blood cells in tumor tissue (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Mutations in DNMT3A were most common, followed by TET2, PPM1D, ASXL1, ATM, and TP53; these six genes accounted for 60% of all mutations detected (Figure 1C).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel C",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "CH demonstrated a statistically significant association with increased age (p<0.001) (Figure 1F) and race (p=0.002) with CH occurring most often in Caucasian patients.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel F",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel F",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The incidence of CH was highest in thyroid cancer patients, possibly related to radioactive iodine exposure, and lowest in patients with germ cell tumors (Figure 2A), with the low rate in germ cell tumors likely attributable to younger age of patients with this malignancy.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "CH demonstrated a statistically significant association with increased age (p<0.001) (Figure 1F) and race (p=0.002) with CH occurring most often in Caucasian patients.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel F",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel F",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The incidence of CH was highest in thyroid cancer patients, possibly related to radioactive iodine exposure, and lowest in patients with germ cell tumors (Figure 2A), with the low rate in germ cell tumors likely attributable to younger age of patients with this malignancy.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Seven of 237 patients with CH-PD developed a hematologic cancer, compared to 12 of 5,157 patients without CH-PD (3.2% (1.4–6.2%) and 0.3% (0.2–0.6%) estimates at 18 months, respectively; p<0.001) (Figure 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Seven of 237 patients with CH-PD developed a hematologic cancer, compared to 12 of 5,157 patients without CH-PD (3.2% (1.4–6.2%) and 0.3% (0.2–0.6%) estimates at 18 months, respectively; p<0.001) (Figure 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  }
]